Status
Conditions
Treatments
About
Albinism is a genetic and hereditary anomaly that affects pigmentation. This pathology is characterized by a deficit in melanin production. In humans, the clinical diagnosis of albinism is based on a number of factors, including :
As treatment options begin to emerge for certain albinism-induced anomalies (including, for example, the depigmentation that causes photophobia), it is desirable to understand what these patients' complaints are, and to gather their views on the emergence of treatments targeting just one of their complaints, namely glare.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
No diagnosis according to Kruijt et al. criteria Impossibility (visual, technological) of completing questionnaire
Loading...
Central trial contact
Amélie Yavchitz
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal